Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 80Rectal Neoplasms 40Colonic Neoplasms 34Pancreatic Neoplasms 27Stomach Neoplasms 22Carcinoma, Hepatocellular 21Breast Neoplasms 21Esophageal Neoplasms 20Neoplasm Metastasis 18Nasopharyngeal Carcinoma 15Esophageal Squamous Cell Carcinoma 13Neoplasms 7Head and Neck Neoplasms 7Liver Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Squamous Cell 5Anus Neoplasms 5Adenocarcinoma Of Esophagus 5Nasopharyngeal Neoplasms 4Inflammatory Breast Neoplasms 4Cholangiocarcinoma 4Recurrence 3Gallbladder Neoplasms 3Breast Neoplasms, Male 3Bile Duct Neoplasms 3Solid Tumors 2Ovarian Neoplasms 2Neutropenia 2Neoplasms, Unknown Primary 2Laryngeal Neoplasms 2

Interventions

Trastuzumab 2Ivabradine 2Exercise 2Echocardiography 2Bisoprolol 2salicylhydroxamic acid 1sacubitril and valsartan sodium hydrate drug combination 1mitoquinone 1epicatechin gallate 1dapagliflozin 1candesartan 1Trimetazidine 1Therapeutics 1Surveys and Questionnaires 1Spironolactone 1Silymarin 1Secondary Prevention 1Restraint, Physical 1Ramipril 1Radiotherapy 1Perindopril 1Neoadjuvant Therapy 1Nebivolol 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Fluorouracil 1Epirubicin 1Docetaxel 1Cyclophosphamide 1Cisplatin 1Carvedilol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cardiotoxicity × Fluorouracil × Clear all
NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡